Have a personal or library account? Click to login
Prophylactic efficacy of some chemoprotectants against abrin induced lethality Cover

Prophylactic efficacy of some chemoprotectants against abrin induced lethality

Open Access
|Mar 2019

References

  1. Bora N, Gadadhar S, Karande AA. (2010). Signaling different pathways of cell death: Abrin induced programmed necrosis in U266B1 cells. Int J Biochem Cell Biol42: 1993–2003.10.1016/j.biocel.2010.08.012
  2. BTWC. (2001). BWC/AD HOC GROUP/56 from the 23rd Session of the Ad Hoc Group of States Parties to the Convention, Geneva, 23 April-11 May 2001.
  3. Dickers KJ, Bradberry SM, Rice P, Griffiths GD, Vale JA. (2003). Abrin poisoning. Toxicol Rev22: 137–42.10.2165/00139709-200322030-00002
  4. Dickey DT, Muldoon LL, Doolittle ND, Peterson DR, Kraemer DF, Neuwelt EA. (2008). Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-inducedtoxicity in rat models. Cancer Chemother Pharmacol. 62: 235–41.10.1007/s00280-007-0597-2
  5. Endo Y, Mitsui K, Motizuki M, Tsurugi K. (1987). The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem262: 5908–12.10.1016/S0021-9258(18)45660-8
  6. Gad SC, Weil CS. (1989). Statistics for toxicologist, In: Principles and methodology of Toxicology 2nd edition edited by AW Hyes. pp, 435–83.Raven Press, New York.
  7. Garg V, Hon YY, Jusko WJ. (1994). Effects of acute and chronic inflammation on the pharmacokinetics of prednisolone in rats. Pharm Res11: 541–4.
  8. Griffiths GD. (2011). Understanding ricin from a defensive viewpoint. 3: 1373–92.10.3390/toxins3111373
  9. Kerksick C, Willoughby D. (2005). The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr9: 38–44.10.1186/1550-2783-2-2-38
  10. Kumar O, Sugendran K, Vijayaraghavan R. (2003). Oxidative stress associated hepatic and renal toxicity induced by ricin in mice. Toxicon41: 333–8.10.1016/S0041-0101(02)00313-6
  11. Kumar O, Kannoji A, Jayaraj R, Vijayaraghavan R. (2008). Purification and characterization of abrin toxin from white Abrus precatorius seeds. J Cell Tissue Res8: 1243–1248.
  12. Miller DJ, Ravikumar K, Shen H, Suh JK, Kerwin SM, Robertus JD. (2002). Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition. J Med Chem45: 90–8.10.1021/jm010186s
  13. Muldoon DF, Hassoun EA, Stohs SJ. (1992). Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice. Toxicon30: 977–84.10.1016/0041-0101(92)90042-4
  14. Muldoon DF, Stohs SJ. (1994). Modulation of ricin toxicity in mice by biologically active substances. J Appl Toxicol14: 81–6.10.1002/jat.2550140204
  15. Niyogi SK. (1977). Elevation of enzyme levels in serum due to Abrus precatorius (jequirity bean) poisoning. Toxicon 15: 577–80.10.1016/0041-0101(77)90109-X
  16. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem95: 351–8.10.1016/0003-2697(79)90738-3
  17. Olsnes S, Pihl A. (1973). Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibitinOlsnes S, Pihl A. Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry12: 3121–6.10.1021/bi00740a028
  18. Olsnes S, Sandvig K, Eiklid K, Pihl A. (1978). Properties and action mechnism of the toxic lectin modeccin: interaction with cell lines resistant to modeccin, abrin, and ricin. J Supramol Struct9: 15–25.10.1002/jss.400090103
  19. Saxena N, Rao PV, Bhaskar AS, Bhutia YD. (2014). Protective effects of certain pharmaceutical compounds against abrin induced cell death in Jurkat cell line. Int Immunopharmacol21: 412–25.10.1016/j.intimp.2014.05.028
  20. Saxena N, Yadav P, Kumar O. (2013). The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis. Toxicol Sci135: 103–18.10.1093/toxsci/kft139
  21. Shih SF, Wu YH, Hung CH, Yang HY, Lin JY. (2001). Abrin triggers cell death by inactivating a thiol-specific antioxidant protein. J Biol Chem276: 21870–21877.10.1074/jbc.M100571200
  22. Shalansky SJ, Pate GE, Levin A, Webb JG. (2005). N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration. Heart 91: 997–999.10.1136/hrt.2004.053579
  23. Singh BN, Shankar S, Srivastava RK. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol82: 1807–21.10.1016/j.bcp.2011.07.093
  24. Sorrenti V, Di Giacomo C, Acquaviva R, Barbagallo I, Bognanno M, Galvano F. (2013). Toxicity of ochratoxin and its modulation by antioxidants: a review. Toxins (Basel)5: 1742–66.10.3390/toxins5101742
  25. Stirpe F, Barbieri L, Battelli MG, Soria M, Lappi DA. (1992). Ribosome-inactivating proteins from plants: present status and future prospects. Biotechnology (N Y)10: 405–12.10.1038/nbt0492-405
  26. Strickson S, Campbell DG, Emmerich CH, Knebel A, Plater L, Ritorto MS, et al. (2013). The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting theubiquitin system. Biochem J451: 427–37.10.1042/BJ20121651
  27. Vijayaraghavan R, Kumar P, Joshi U, Raza SK, Lakshmana Rao PV, Malhotra RC, et al. (2001). Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity. Toxicology163: 83–91.10.1016/S0300-483X(01)00369-9
  28. Yuan L, Betz JM, Bindra JS, Bobzin SC. (2012). Drug Discovery and Traditional Chinese Medicine: Science, Regulation, and Globalization. Springer Science & Business Media, ISBN: 9780792374114.
  29. Zou P, Song J, Jiang B, Pei F, Chen B, Yang X, et al. (2014). Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse. Int J Clin Exp Pathol7: 4607–16.
DOI: https://doi.org/10.2478/intox-2018-0013 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 169 - 177
Submitted on: Sep 12, 2016
|
Accepted on: Nov 23, 2017
|
Published on: Mar 2, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Nandita Saxena, Yangchen Doma Bhutia, Om Kumar, Pooja Phatak, Ramesh Kumar Kaul, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.